![Peter Alff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Alff active positions
Companies | Position | Start | End |
---|---|---|---|
Actinobac Biomed, Inc.
![]() Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Director/Board Member | - | - |
Opera Therapeutics, Inc.
![]() Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Director/Board Member | - | - |
President | - | - | |
Symbiotix Biotherapies, Inc.
![]() Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Director/Board Member | - | - |
Career history of Peter Alff
Statistics
International
United States | 4 |
Operational
Director/Board Member | 3 |
President | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Actinobac Biomed, Inc.
![]() Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Symbiotix Biotherapies, Inc.
![]() Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Health Technology |
Opera Therapeutics, Inc.
![]() Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Peter Alff
- Experience